Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for vascular disease

E C Svensson1, L B Schwartz

  • 1Department of Medicine, University of Chicago, IL 60637, USA.

Current Opinion in Cardiology
|November 21, 1998
PubMed
Summary

Gene therapy offers new hope for vascular disease, addressing restenosis and intimal hyperplasia after mechanical interventions. Advances in gene delivery vectors and therapeutic angiogenesis show promise for improved long-term efficacy in treating occlusive vascular lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials.

Human reproduction (Oxford, England)·2016
Same author

Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.

Allergy·2014
Same author

Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

Annals of oncology : official journal of the European Society for Medical Oncology·2014
Same author

Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis.

Allergy·2012
Same author

Serum total tryptase levels are increased in patients with active chronic urticaria.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2010
Same author

Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy).

Allergy·2008

Area of Science:

  • Cardiovascular Medicine
  • Molecular Biology
  • Biotechnology

Background:

  • Vascular disorders are a major cause of mortality and morbidity.
  • Mechanical interventions like angioplasty and bypass grafting are common but face limitations.
  • Restenosis and intimal hyperplasia reduce the long-term success of vascular treatments.

Purpose of the Study:

  • To review the latest advancements in gene therapy for vascular disease.
  • To highlight new strategies for preventing complications following vascular interventions.
  • To discuss novel approaches including gene delivery, restenosis treatment, and therapeutic angiogenesis.

Main Methods:

  • Review of current research in vascular gene therapy.
  • Focus on recombinant DNA technology applications.

Related Experiment Videos

  • Analysis of new vectors for gene delivery.
  • Examination of therapeutic angiogenesis strategies.

    • Main Results:

    • Development of novel gene therapy vectors for enhanced vascular gene delivery.
    • Emerging treatments targeting angioplasty-induced restenosis and vein graft intimal hyperplasia.
    • Progress in therapeutic angiogenesis for vascular repair.

    Conclusions:

    • Gene therapy presents a promising frontier for managing vascular disease complications.
    • New technologies are improving the efficacy of treatments for restenosis and intimal hyperplasia.
    • Therapeutic angiogenesis holds potential for vascular regeneration and improved patient outcomes.